Confronting multidrug-resistant Acinetobacter baumannii: a review.
Int J Antimicrob Agents. 2010 Dec 2;
Authors: Neonakis IK, Spandidos DA, Petinaki E
Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described.
PMID: 21130607 [PubMed - as supplied by publisher]